Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone.
The pharmacological profile of naltrindole (NTI) and three of its analogues, N-methyl-NTI (N-Me-NTI), oxymorphindole (OMI) and naltriben (NTB) were studied in antinociceptive assays. The compounds were found to have agonist activities that appear to be mediated mainly by kappa opioid receptors because norbinaltorphimine (nor-BNI), the selective kappa opioid receptor antagonist inhibited their effects significantly. All of the compounds, behaved as antagonists at doses that were lower than those that produced agonist effects and they possessed a profile that was very selective for inhibiting the antinociceptive activities of delta opioid receptor agonists. Differential antagonism by NTB of the activities of DSLET and DPDPE was demonstrated.
Takemori
A E
AE
Department of Pharmacology, Medical School, University of Minnesota, Minneapolis 55455.
Sultana
M
M
Nagase
H
H
Portoghese
P S
PS
D000818:Animals; D007211:Indoles / Q000494:pharmacology; D008024:Ligands; D008297:Male; D051379:Mice; D009019:Morphinans / Q000494:pharmacology; D009025:Morpholines / Q000494:pharmacology*; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology*; D011957:Receptors, Opioid / Q000187:drug effects*; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa
D007211:Indoles; D008024:Ligands; D009019:Morphinans; D009025:Morpholines; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; C070418:oxymorphindole; C074392:N-methylnaltrindole; C068868:naltrindole benzofuran; D009271:Naltrexone; C055382:naltrindole